Linking Myocardium Hypercontractility to Microvasculature Dysfunction and Inflammation through NLRP3 Inflammasome Activation

Linking Myocardium Hypercontractility to Microvasculature Dysfunction and Inflammation through NLRP3 Inflammasome Activation

Saved in:

Bibliographic Details
Main Authors:	Vasco Sequeira, Katharina Ermer, Jan M. Federspiel, Mark Waddingham, Jan Dudek, Hirotsugu Tsuchimochi, Christoph Maack, James Pearson
Format:	Article
Language:	English
Published:	Elsevier 2024-11-01
Series:	Journal of Molecular and Cellular Cardiology Plus
Online Access:	http://www.sciencedirect.com/science/article/pii/S2772976124000473
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

Exploring Macrophage Polarization and Immune Response Dynamics: The Impact of mature Cardiolipin in a TAFAZZIN-Deficient Model
by: Katharina Ermer, et al.
Published: (2024-11-01)

Metabolic Dysfunction in the Regulation of the NLRP3 Inflammasome Activation: A Potential Target for Diabetic Nephropathy
by: Wenli Zhao, et al.
Published: (2022-01-01)

Activation of NLRP3 inflammasome in patients with renal transplantation: relation to allograft dysfunction, inflammation, and renal fibrosis
by: Hayam Abdel Meguid El Aggan, et al.
Published: (2024-12-01)

Function of NLRP3 inflammasome activation in multiple myeloma
by: Xiaorong Zhu, et al.
Published: (2024-12-01)

Irisin Attenuates Neuroinflammation Targeting the NLRP3 Inflammasome
by: Francesca Martina Filannino, et al.
Published: (2024-11-01)

NLRP3 Inflammasome-Mediated Osteoarthritis: The Role of Epigenetics
by: Yuzhou Liu, et al.
Published: (2025-01-01)

Understanding the Role of NLRP3 Inflammasome in Acute Pancreatitis
by: Konstantinos Papantoniou, et al.
Published: (2024-11-01)

NLRP3 Inflammasome Activation Is Involved in Geniposide-Induced Hepatotoxicity
by: Yixuan Liu, et al.
Published: (2025-01-01)

Trimethylamine-N-Oxide Promotes High-Glucose-Induced Dysfunction and NLRP3 Inflammasome Activation in Retinal Microvascular Endothelial Cells
by: Lidan Xue, et al.
Published: (2023-01-01)

Inflammasome-targeted therapy for oral cancer: Highlighting NLRP3 inflammasome as a promising clinical therapeutic target
by: Geetha Shanmugam
Published: (2024-06-01)

Targeting the NLRP3 inflammasome abrogates cardiotoxicity of immune checkpoint blockers
by: Ping Li, et al.
Published: (2025-01-01)

Recent Advances of the NLRP3 Inflammasome in Central Nervous System Disorders
by: Keren Zhou, et al.
Published: (2016-01-01)

NLRP3 Inflammasome: Activation and Regulation in Age-Related Macular Degeneration
by: Jiangyuan Gao, et al.
Published: (2015-01-01)

The role of NLRP3 inflammasome in type 2 inflammation related diseases
by: Shenming Xu, et al.
Published: (2024-12-01)

Gubentongluo decoction alleviates NLRP3 inflammasome in IgAN cell model
by: Wei Meng, et al.
Published: (2023-12-01)

Tranilast directly targets NLRP3 to treat inflammasome‐driven diseases
by: Yi Huang, et al.
Published: (2018-03-01)

New insight into the role of the pathway NLRP1 and NLRP3 inflammasomes and IL-33 in ultraviolet-induced cutaneous carcinogenesis
by: Aleksandra Lesiak, et al.
Published: (2025-01-01)

<i>MYBPC3</i> D389V Variant Induces Hypercontractility in Cardiac Organoids
by: Darshini Desai, et al.
Published: (2024-11-01)

Obstructive sleep apnea, the NLRP3 inflammasome and the potential effects of incretin therapies
by: Michelle Wei, et al.
Published: (2025-01-01)

Metformin Ameliorates Ulcerative Colitis Through Inhibiting NLRP3 Inflammasome Activation
by: Cao R, et al.
Published: (2025-02-01)

The effect of NLRP3 inflammasome on cardiovascular prognosis in patients with acute coronary syndrome
by: De-Gang Mo, et al.
Published: (2025-01-01)

Oxidative Stress and the NLRP3 Inflammasome: Focus on Female Fertility and Reproductive Health
by: Efthalia Moustakli, et al.
Published: (2025-01-01)

Formononetin ameliorates polycystic ovary syndrome through suppressing NLRP3 inflammasome
by: Zhuo Liu, et al.
Published: (2025-01-01)

The NLRP3 Inflammasome as a Novel Player of the Intercellular Crosstalk in Metabolic Disorders
by: Elisa Benetti, et al.
Published: (2013-01-01)

Effect of NLRP3 inflammasome induced astrocyte phenotype alteration in morphine tolerance
by: Zhenyu Yuan, et al.
Published: (2024-11-01)

Definitional Challenges in Understanding Hypertrophic Cardiomyopathy
by: Jan M. Federspiel, et al.
Published: (2024-11-01)

Carvacrol alleviates LPS-induced myocardial dysfunction by inhibiting the TLR4/MyD88/NF-κB and NLRP3 inflammasome in cardiomyocytes
by: Lu Xu, et al.
Published: (2024-11-01)

Asthma-associated prostate enlargement and bladder smooth muscle hypercontractility: unveiling a potential link to LUTS
by: Peibin Cen, et al.
Published: (2025-01-01)

Apigenin inhibits NLRP3 inflammasome activation in monocytes and macrophages independently of CD38
by: Knut Husø Lauritzen, et al.
Published: (2025-01-01)

Antituberculosis Drugs (Rifampicin and Isoniazid) Induce Liver Injury by Regulating NLRP3 Inflammasomes
by: Qiang Su, et al.
Published: (2021-01-01)

The Role and the Regulation of NLRP3 Inflammasome in Irritable Bowel Syndrome: A Narrative Review
by: Arezina Kasti, et al.
Published: (2025-01-01)

Natural Compounds as Regulators of NLRP3 Inflammasome-Mediated IL-1β Production
by: József Tőzsér, et al.
Published: (2016-01-01)

Comparison of Different Keratinocyte Cell Line Models for Analysis of NLRP1 Inflammasome Activation
by: Tian Wang, et al.
Published: (2024-11-01)

Inhibition of the PERK/TXNIP/NLRP3 Axis by Baicalin Reduces NLRP3 Inflammasome-Mediated Pyroptosis in Macrophages Infected with Mycobacterium tuberculosis
by: Yan Fu, et al.
Published: (2021-01-01)

Diastolic dysfunction of myocardium and change of <i>Q–T</i> interval at chronic hepatitis C
by: A. A. Konysheva, et al.
Published: (2012-11-01)

Characterization of Transverse Aortic Constriction in Mice Based on the Specific Recruitment of Leukocytes to the Hypertrophic Myocardium and the Aorta Ascendens
by: Jan Lukas Kleiner, et al.
Published: (2021-01-01)

Role of peroxisomes in compensatory metabolic adaptation in Barth syndrome Cardiomyopathy
by: Elsie Vidah Kajese, et al.
Published: (2024-11-01)

Gut microbiota: a novel target for exercise-mediated regulation of NLRP3 inflammasome activation
by: Jun Chen, et al.
Published: (2025-01-01)

α-amanitin induces hepatotoxicity via PPAR-γ inhibition and NLRP3 inflammasome activation
by: Haowei Wang, et al.
Published: (2025-01-01)

Puerariae Radix protects against ulcerative colitis in mice by inhibiting NLRP3 inflammasome activation
by: Yu Ga, et al.
Published: (2024-07-01)